Ona Therapeutics is a biotechnology company founded in 2019 and headquartered in Barcelona, Spain, specializing in the design of first-in-class biotherapeutics and ADCs to attack advanced cancer.
Subscribe to see Ona Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Ona Therapeutics is a drug discovery company headquartered in Barcelona, Spain. It has raised at least $121.4M across the 2 funding rounds on record. Its most recent funding round, Series B, raised $86.6M in April 2026. Xcout tracks 16 named people at Ona Therapeutics, including Julià Mesquida (Chief Financial Officer).
As of 16 November 2026. Source: Xcout Intel.
10 more named people on record for Ona Therapeutics, with roles, board committees and tenure — see the full roster →
At least $121.4M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $86.6M | 10 named | |
| Series A | $34.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Ona Therapeutics's closest competitors — see the full list of competitors and alternatives →
Peptomyc is a clinical-stage biotechnology company headquartered in Barcelona, Spain, specializing in the development of protein and peptide therapeutics for cancer.
LyncBio Therapeutics is an innovative drug discovery and development company headquartered in Shanghai, China, with research facilities in Suzhou. The firm specializes in the advancement of antibody-drug conjugate (ADC) therapeutics.
OncoMyx Therapeutics, Inc. is a biotechnology company headquartered in Phoenix, Arizona, that develops innovative oncolytic immunotherapies to target and destroy tumors.
Diagonal Therapeutics is a biotechnology company headquartered in Watertown, Massachusetts, pioneering disease-modifying clustering antibody therapeutics to target the root causes of devastating diseases.
Founded in 2021 and headquartered in Shenzhen, China, MagicRNA Biotechnology Co., Ltd. is a clinical-stage biotechnology company focused on nucleic acid drug delivery and the research and development of next-generation mRNA and lipid nanoparticle technologies for the treatment of cancer and infectious diseases.
Orbital Therapeutics is a biotechnology company developing RNA medicines, with a focus on engineered circular RNA and delivery technologies. Its programs are intended to address diseases that may benefit from durable, programmable protein expression, serving patients and healthcare providers through potential therapeutic products.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Ona Therapeutics? Suggest a correction · Work at Ona Therapeutics? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.